SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 53.47 |
| Enterprise Value ($M) | 9.64 |
| Book Value ($M) | 96.58 |
| Book Value / Share | 2.02 |
| Price / Book | 0.55 |
| NCAV ($M) | 83.60 |
| NCAV / Share | 1.75 |
| Price / NCAV | 0.64 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.74 |
| Return on Assets (ROA) | -0.47 |
| Return on Equity (ROE) | -0.51 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 7.96 |
| Current Ratio | 7.96 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 98.74 |
| Assets | 111.72 |
| Liabilities | 15.14 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | Redmile Group, LLC | 11.80 | -0.70 | |
| 13G/A | Prosight Management, LP | 14.00 | 24.49 | |
| 13G/A | Vanguard Group Inc | 5.03 | 0.00 | |
| 13G | BlackRock, Inc. | 5.50 | 0.00 | |
| 13G/A | Fmr Llc | 0.28 | -98.10 | |
| 13G | Adage Capital Partners Gp, L.l.c. | 5.47 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 20,432 | 44,215 | 46.21 | |
| 16,791 | 65,029 | 25.82 | |
| 33,143 | 90,384 | 36.67 | |
| 35,833 | 125,702 | 28.51 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| SRPT – Sarepta Therapeutics, Inc. | SRRK – Scholar Rock Holding Corporation |
| STOK – Stoke Therapeutics, Inc. | SVRA – Savara Inc. |
| SWTX – SpringWorks Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io